Altimmune Q3 EPS $(0.39) Vs $(0.48) Last Year, Sales $362.00K Up From $2.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Altimmune (NASDAQ:ALT) reported Q3 losses of $(0.39) per share, an 18.75% improvement from $(0.48) per share last year. The company's sales for the quarter were $362.00K, a significant increase from $2.00K in the same period last year.
November 07, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Altimmune reported improved Q3 losses and a significant increase in sales compared to the same period last year.
Altimmune's improved earnings and significant sales increase indicate a positive financial performance, which could lead to a short-term increase in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100